Open | - |
Close | - |
Volume / Avg. | 0 / 69.615K |
Day Range | - - - |
52 Wk Range | 0.220 - 1.600 |
Market Cap | $9.703M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 26 |
Short Interest | 0.32% |
Days to Cover | 1.51 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NLS Pharmaceutics (NASDAQ: NLSP) through any online brokerage.
There are no as such competitors for NLS Pharmaceutics.
The latest price target for NLS Pharmaceutics (NASDAQ: NLSP) was reported by Maxim Group on Thursday, September 14, 2023. The analyst firm set a price target for 0.00 expecting NLSP to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for NLS Pharmaceutics (NASDAQ: NLSP) is $0.272 last updated March 18, 2024 at 7:30 PM EDT.
There are no upcoming dividends for NLS Pharmaceutics.
NLS Pharmaceutics’s FY earnings are confirmed for Friday, May 3, 2024.
There is no upcoming split for NLS Pharmaceutics.
NLS Pharmaceutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.